Infant Bacterial Therapeutics AB
IBT-B.ST
#9222
Rank
NZ$0.12 B
Marketcap
$9.23
Share price
-0.56%
Change (1 day)
-32.07%
Change (1 year)

EPS for Infant Bacterial Therapeutics AB (IBT-B.ST)

EPS in 2024 (TTM): -$1.55

According to Infant Bacterial Therapeutics AB's latest financial reports the company's current EPS (TTM) is -$1.58. In 2023 the company made an earnings per share (EPS) of -$1.66 a decrease over its 2022 EPS that were of -$0.94.

EPS history for Infant Bacterial Therapeutics AB from 2014 to 2024

Annual EPS

Year EPS Change
2024 (TTM)-$1.55-6.65%
2023-$1.6676.22%
2022-$0.9426.49%
2021-$0.74-43.37%
2020-$1.3177.11%
2019-$0.745.56%
2018-$0.70-43.39%
2017-$1.24-10.87%
2016-$1.39-30.65%
2015-$2.01359.45%
2014-$0.44